Axogen (AXGN) Capital Expenditures Growth (5y) (2016 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Axogen | 2.00 Bn | 1.90 Bn | 46.19 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -2.06% |
| Dec 31, 2025 | -29.84% |
| Sep 30, 2025 | 14.97% |
| Jun 30, 2025 | -15.02% |
| Mar 31, 2025 | -41.30% |
| Dec 31, 2024 | -7.47% |
| Sep 30, 2024 | -6.24% |
| Jun 30, 2024 | -42.12% |
| Mar 31, 2024 | 1.54% |
| Dec 31, 2023 | 124.17% |
| Sep 30, 2023 | -16.85% |
| Jun 30, 2023 | -59.91% |
| Mar 31, 2023 | 64.25% |
| Dec 31, 2022 | 68.43% |
| Sep 30, 2022 | 77.28% |
| Jun 30, 2022 | 72.06% |
| Mar 31, 2022 | 119.71% |
| Dec 31, 2021 | 41.44% |
| Sep 30, 2021 | -128.76% |
| Jun 30, 2021 | 170.58% |
| Mar 31, 2021 | 50.34% |
| Dec 31, 2020 | 157.83% |
| Sep 30, 2020 | -123.68% |
| Jun 30, 2020 | 137.36% |
| Mar 31, 2020 | 257.54% |
| Dec 31, 2019 | 37.75% |
| Sep 30, 2019 | 120.68% |
| Jun 30, 2019 | 0.23% |
| Mar 31, 2019 | 19.58% |
| Dec 31, 2018 | 15.44% |
| Sep 30, 2018 | 202.68% |
| Jun 30, 2018 | 72.39% |
| Mar 31, 2018 | 69.14% |
| Dec 31, 2017 | 113.44% |
| Sep 30, 2017 | 108.13% |
| Jun 30, 2017 | 174.37% |
| Mar 31, 2017 | 27.40% |
| Dec 31, 2016 | -116.49% |